Report: Affordable Care Act won't create windfall for devicemakers; Court sides with CA hospital in 'secret' Stryker test;

 @FierceMedDev: EU proposes tougher medical device rules in light of breast implant scandal. More | Follow @FierceMedDev

 @DamianFierce: Smith & Nephew has issued a device failure warning for one of its all-metal hip implants. More | Follow @DamianFierce

> The Affordable Care Act, bearer of the 2.3% excise tax, is said to be a blessing in disguise for the medical device industry, as expanding the ranks of the insured will mean more customers for devicemakers. However, according to a report from Roth Capital Partners, that claim's not all its cracked up to be. Analysis

> A California court has sided with the hospital board accused of conducting secret tests of a Stryker ($SYK) bone growth product, saying the hospital does not have to produce internal documents on the issue. News

> Startup Spiritus Tech has developed a cuff inflation syringe that addresses the risks of underinflation in endodtracheal intubations. Article

> Precision Spine snagged 510(k) clearance for its ReForm pedicle screw system, designed to stabilize spinal segments. More

> Advanced Brain Monitoring picked up FDA clearance for its neuro-cardio diagnostic tool, Sleep Profiler, which assesses sleep architecture and continuity. Item

> Dallen Medical is seeking an FDA nod for its Compressyn staple for small bone fixation, targeted to foot, ankle and hand applications. Release

> German medical device and component company Helix Medical is opening a new facility in Costa Rica. Release

Biotech News

 @FierceBiotech: Tagging the lows: RNA biomarkers personalize depression treatment. More | Follow @FierceBiotech

 @RyanMFierce: Ouch. Cardiome doesn't have much to fall back on after this Afib program that Merck has dropped back in its lap. More | Follow @RyanMFierce

> Biogen races to FDA with positive PhIII data for hemophilia B drug. Article

> FDA seeks ways to boost antibacterial drug pipeline. Story

> Merck hands back heart-drug rights to struggling Cardiome. Item

Pharma News

 @FiercePharma: Did Valeant bid too high for Medicis? Analysts cite flagging scripts for lead drug, Solodyn. More | Follow @FiercePharma

> J&J aimed Risperdal pitch at childrens' doctors, witness says. Story

> Reckitt petitions FDA to force 'child resistant' packaging on Suboxone rivals. Article

> Is Valeant's $2.6B price for Medicis too high? More

Biomarkers News

> Marker picks out the right people for stroke therapy. More

> Genes power bowel cancer marker panel. News

> Cutting through the silence of heart disease. Article

Durg Delivery News

> Pulsing nanotubes pump out drugs. Story

> SkyePharma's Flutiform launches in Germany, Kyorin seeks OK in Japan. News

> Boston Scientific's stent opens blood vessels and European markets. Article

Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.